Completed NA INTERVENTIONAL 1-arm NCT01998074

Evaluation of the Efficacy of a New Formula in Infants With Cow's Milk Protein Allergy (Paradice)

Evaluation of the Efficacy of a New Extensively Hydrolyzed Formula in Infants With Cow's Milk Protein Allergy

Sponsor: United Pharmaceuticals

Conditions Food Sensitivity Milk Hypersensitivity Protein Allergy

Interventions extensively hydrolyzed rice protein formula

Updated 6 times since 2017 Last updated: Nov 27, 2013 Primary completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01998074, this NA trial focuses on Food Sensitivity and Milk Hypersensitivity and remains completed. Sponsored by United Pharmaceuticals, it has been updated 6 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

United Pharmaceuticals

Data source: United Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium